Despegar.com (DESP) Reaches New 52-Week High and Low at $21.83

Share on StockTwits

Despegar.com Corp (NYSE:DESP) hit a new 52-week high and low during trading on Thursday . The stock traded as low as $21.83 and last traded at $22.35, with a volume of 11436 shares changing hands. The stock had previously closed at $22.28.

DESP has been the subject of several recent research reports. Zacks Investment Research raised Despegar.com from a “sell” rating to a “hold” rating and set a $36.00 price target for the company in a research note on Monday, March 12th. Morgan Stanley reaffirmed an “equal weight” rating and set a $33.00 target price (up previously from $32.00) on shares of Despegar.com in a research report on Friday, March 9th. Citigroup upped their target price on Despegar.com from $36.00 to $37.00 and gave the stock a “neutral” rating in a research report on Friday, March 9th. Finally, R. F. Lafferty started coverage on Despegar.com in a research report on Monday, March 12th. They set a “buy” rating and a $38.00 target price for the company. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Despegar.com has a consensus rating of “Buy” and a consensus price target of $36.63.

The stock has a market capitalization of $1.55 billion and a PE ratio of 32.23.

Despegar.com (NYSE:DESP) last issued its quarterly earnings results on Thursday, May 10th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. The business had revenue of $148.60 million for the quarter, compared to analyst estimates of $143.47 million. The company’s revenue was up 18.9% compared to the same quarter last year. sell-side analysts anticipate that Despegar.com Corp will post 0.78 EPS for the current year.

Several hedge funds have recently modified their holdings of the company. BlackRock Inc. acquired a new position in shares of Despegar.com during the fourth quarter worth approximately $142,000. Champlain Investment Partners LLC raised its stake in shares of Despegar.com by 16.1% in the first quarter. Champlain Investment Partners LLC now owns 43,670 shares of the company’s stock valued at $1,365,000 after purchasing an additional 6,070 shares in the last quarter. State of New Jersey Common Pension Fund D acquired a new position in shares of Despegar.com in the first quarter valued at $209,000. Jane Street Group LLC acquired a new position in shares of Despegar.com in the first quarter valued at $227,000. Finally, GSA Capital Partners LLP acquired a new position in shares of Despegar.com in the first quarter valued at $243,000. Institutional investors own 74.03% of the company’s stock.

About Despegar.com

Despegar.com, Corp., an online travel company, provides a range of travel and travel-related products through its Websites and mobile applications in Latin America. It operates through two segments, Air; and Packages, Hotels and Other Travel Products. The company offers airline tickets, packages, hotels, and other travel-related products under the Despegar and Decolar brands, which enable consumers to find, compare, plan, and purchase travel products through its marketplace.

Receive News & Ratings for Despegar.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Despegar.com and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Axiom Price Reaches $0.0078 on Exchanges
Axiom Price Reaches $0.0078 on Exchanges
Starta Hits 24-Hour Trading Volume of $0.00
Starta Hits 24-Hour Trading Volume of $0.00
Zacks: Brokerages Expect MTS Systems Co.  Will Announce Earnings of $0.63 Per Share
Zacks: Brokerages Expect MTS Systems Co. Will Announce Earnings of $0.63 Per Share
Obalon Therapeutics  Getting Somewhat Positive Media Coverage, Study Shows
Obalon Therapeutics Getting Somewhat Positive Media Coverage, Study Shows
Novus Therapeutics  Receives News Impact Score of 0.16
Novus Therapeutics Receives News Impact Score of 0.16
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc  This Quarter
$4.68 Earnings Per Share Expected for Regeneron Pharmaceuticals Inc This Quarter


Leave a Reply

 
© 2006-2018 Zolmax.